9.30 USD
↘ 0.07 (0.75%)AT CLOSE (11:59 AM EDT)
Climb Bio, Inc. Common Stock
CLYMNASDAQ • USD
9.20
↘ 0.10 (1.06%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
9.20
↘ 0.10 (1.06%)
Market: CLOSED
Open?$9.46
High?$10.00
Low?$9.11
Prev. Close?$9.37
Volume?1.5M
Avg. Volume?507.7K
VWAP?$9.60
Rel. Volume?3.02x
Bid / Ask
Bid?$9.10 × 100
Ask?$9.30 × 4.9K
Spread?$0.20
Midpoint?$9.20
Valuation & Ratios
Market Cap?447.6M
Shares Out?47.8M
Float?32.0M
Float %?67.1%
P/E Ratio?N/A
P/B Ratio?2.79
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.16Strong
Quick Ratio?15.16Strong
Cash Ratio?5.11Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.79CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.1CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-37.3%WEAK▾
ROA?-35.7%WEAK▾
Cash Flow & Enterprise
FCF?$-54542000
Enterprise Value?$411.9M
News
Profile
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Employees
29
Market Cap
447.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-08-10
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596